03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
MethylPrednisolone Mylan 1g : | |
Type | Medicine Authorised |
Originator | Solu-Medrol 1g |
Agent | Benta Trading Co |
Distributor | Benta Trading Co |
Laboratory | Mylan |
Manufacturer | Benta SAL |
Manufacturing Type | Benta SAL under license from Mylan S.A.S. France |
Origin | Lebanon |
ATC | H02AB04 |
MethylPrednisolone Mylan 1g :
MethylPrednisolone Mylan 1g :
MethylPrednisolone Mylan 1g :
MethylPrednisolone Mylan 1g :
MethylPrednisolone Mylan 1g :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
MethylPrednisolone Mylan 1g :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abnormal dreams | Rare |
Acne | Not known |
Adrenal cortex atrophy | Not known |
Anaphylactic reactions | Rare |
Arrhythmia | Not known |
Aseptic necrosis of bone | Not known |
Bradycardia | Not known |
Cardiac arrest | Not known |
Cardiovascular collapse | Not known |
Cataract | Not known |
Confusional state | Rare |
Congestive heart failure | Not known |
Convulsion | Rare |
Cushing's syndrome | Not known |
Ecchymosis | Not known |
Euphoria | Common |
Excitement | Common |
Fluid retention | Not known |
Gastric haemorrhage | Not known |
Gastric perforation | Not known |
Gastroduodenal ulcer | Not known |
Glaucoma | Not known |
Glucose tolerance decreased | Not known |
Growth failure | Not known |
Hip osteonecrosis | Not known |
Hypertension | Not known |
Hypertrichosis | Not known |
Hypokalaemia | Not known |
Insomnia | Common |
Latent diabetes | Not known |
Menstrual disorder | Not known |
Metabolic alkalosis | Not known |
Muscle atrophy | Not known |
Muscle weakness | Not known |
Osteoporosis | Not known |
Pancreatitis acute | Not known |
Pathological fracture | Not known |
Purpura | Not known |
Sodium retention | Not known |
Tachycardia | Rare |
Tendon rupture | Very rare |
Vertebral collapse | Not known |
Wound healing delayed | Not known |
MethylPrednisolone Mylan 1g :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
MethylPrednisolone Mylan 1g MoH 6904 :
Form | Powder for solution for injection |
Packaging | Vial (Type I Glass) |
Package Size | Box of 1 |
Strength | 1g |
Public Price | 1259207.41 L.L. |
Stratum | A2 |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 97214/12 |
Submission date | 01/01/2012 |
Registration Year | 2012 |
Price Comparison
● Country: | Tunisia | |
● Package Size: | Boîte de 1 | |
● Public Price: | 150.8 TND | ( 4,352,842.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 150,8 TND | ( 4,329,750.00 LBP ) |
● Pricing Date: | 04/02/2019 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Powder for solution for injection | |
● Package Size: | Box of 1 | |
● Public Price: | 1259207.41 LBP | ( 1,259,207.41 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1259207,41 LBP | ( 1,259,207.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | France |
● Package Size: | 10 |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File